• Skip to main content
  • Skip to navigation
Home

YEDA Technology Transfer from the Weizmann Institute of Science

Yeda Research and Development

Contact Us
Briefcase
Become a member
Menu
  • Home
  • About Us
    • About Us
    • Our Team
    • Board of Directors
    • Close
  • Technologies
    • Agriculture and Plant Genetics
    • Chemistry and Nanotechnology
    • Diagnostics
    • Environmental Sciences and Solar Energy
    • Mathematics and Computer Science
    • Medical Devices
    • Pharmaceuticals
    • Physics and Electro-Optics
    • Research Tools
    • Close
  • Success Stories
  • Our spinoffs
  • News & events
    • News & events
    • Newsletters
    • Close
  • For researchers
  • Become a Member
  • Close
  • Technologies(138)
  • Research Experts(91)
  • Success Stories(3)
  • Our Spinoffs(31)
  • News & Events(106)

You are here

  1. Home ›
  2. Search ›
  3. Technologies

Results for technologies (3)

Advanced filter
Research Tools

Anti importin beta1 monoclonal antibody (No. M7-2223)

A highly specific and sensitive anti-Importin b1 (KPNB1) monoclonal antibody. The mAb recognizes an epitope comprising residues 301-320 of human KPBN1 and is highly specific for cytoplasmic KPNB1 in diverse applications. Importin b1 (KPNB1) is a nucleocytoplasmic transport factor... Read more
Full Professor Michael Fainzilber

Michael Fainzilber

Faculty of Biochemistry

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
17648
Pharmaceuticals

Treating Chronic Pain by Inhibiting Importin Alpha 3 (No. T4-2040)

Pain, particularly in cases of chronic nerve injury and disease, is a critical element of numerous medical conditions and procedures, which is generally managed with opioid analgesics. Neuropathic pain is the pain sensed following injury or chronic progressive nerve disease and ar... Read more
Full Professor Michael Fainzilber

Michael Fainzilber

Faculty of Biochemistry

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
6118
Pharmaceuticals

Treatment of Psychiatric Disorders by Inhibiting Importin Alpha 5 (No. T4-1875)

Anxiety and stress-related conditions pose a significant health burden on modern healthcare systems. While currently, available anxiolytic drugs can be highly effective for some patients, their long-term use is limited by their potentially severe and debilitating side effects. The group of P... Read more
Full Professor Michael Fainzilber

Michael Fainzilber

Faculty of Biochemistry

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
5719

User login

  • Home
  • About Us
    • About Us
    • Our Team
    • Board of Directors
    • Close
  • Technologies
    • Agriculture and Plant Genetics
    • Chemistry and Nanotechnology
    • Diagnostics
    • Environmental Sciences and Solar Energy
    • Mathematics and Computer Science
    • Medical Devices
    • Pharmaceuticals
    • Physics and Electro-Optics
    • Research Tools
    • Close
  • Success Stories
  • Our spinoffs
  • News & events
  • For researchers
  • Become a Member
  • Close

footer

Yeda Research & Development Co. Ltd, P.O Box 95, Rehovot 7610002, Israel
Tel. +972.8.9470617 | Fax. +972.8.9470739
Privacy-Policy youtube twitter facebook linkedin instagram